Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Glycomimetics Has Started Dosing The First Cohort Of Healthy Volunteers In A Phase 1A Study Of GMI-1687 To Evaluate Safety, Tolerability, And Pharmacokinetics; Initial Results Are Expected By The End Of Q1 2024

Author: Benzinga Newsdesk | September 06, 2023 07:13am

Posted In: GLYC